Podcast appearances and mentions of johnson jnj

"You cannot not believe in science," says Tsvetta Kaleynska. She sees biotech companies outperforming in 2025 despite a slow start to the year. Tsvetta argues investors need to understand that many companies don't just produce medicine, but also medical supplies, which contributes to profits. She sees Abivax (ABVX) as an international outperformer and expects Eli Lilly (LLY) to make a comeback in the weight loss drug market. George Tsilis highlights example options trades in Eli Lilly and Johnson & Johnson (JNJ).======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Johnson & Johnson (JNJ) boosted its full-year guidance while taking tariffs into account. Diane King Hall talks about its new acquisitions as a reason behind company confidence. Meanwhile, Albertsons (ACI) traded lower after its guidance disappointed investors. Analysts lean more bearish on General Motors (GM) after both Barclays and Deutsche Bank downgraded the stock.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Johnson & Johnson (JNJ) posted notable strengths in their earnings Tuesday. Jeff Jonas points to the company's pharmaceuticals sector as the highlight, arguing the company has a great pipeline which can withstand tariffs. One overhang: the company's talc lawsuit. Jeff thinks Johnson & Johnson paying the $10 billion settlement is the best route it can make to move forward.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Rebecca Walser joins Nicole Petallides at the NYSE desk to discuss her Sep. 2024 call for a 30% pullback in the stock market. She explains her rationale and examines bigger trends in the marketplace including A.I. and competition overseas. Rebecca details her upside cases for a few stock picks, including: Meta Platforms (META), The Trade Desk (TTD) and Johnson & Johnson (JNJ). 0:00-0:40 Introduction0:41-2:11 Rebecca's 30% Pullback Call2:12-3:28 Bullish Case for Gold3:29-5:30 2025 Market Weakness5:31-7:30 U.S. and China Competition7:31-8:50 Crypto and Bitcoin Outlook8:51-11:36 Market Volatility Picture11:37-15:08 Rebecca's Pick: META15:09-16:09 Rebecca's Pick: TTD16:10-17:10 Rebecca's Pick: JNJ17:11-26:30 What's Next in 2025======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Jeff Jonas, CFA (Portfolio Manager) discusses Johnson & Johnson's recent legal battles and resilience throughout.To learn more about Gabelli Funds' fundamental, research-driven approach to investing, visit https://m.gabelli.com/gtv_cu or email invest@gabelli.com.Connect with Gabelli Funds:• Twitter - https://twitter.com/InvestGabelli• Instagram - https://www.instagram.com/investgabelli/ • Facebook - https://www.facebook.com/InvestGabelli • LinkedIn - https://www.linkedin.com/company/investgabelli/ http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554)

Johnson & Johnson (JNJ) faces new legal obstacles in its baby powder lawsuit. Delta Airlines (DAL) and several competing airlines caught downgrades from Jefferies. And, Micron (MU) gets a bullish note from Citi. Tom White runs through some of the biggest premarket moves ahead of Tuesday's open.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – / schwabnetwork Follow us on Facebook – / schwabnetwork Follow us on LinkedIn - / schwab-network About Schwab Network - https://schwabnetwork.com/about

Stocks closed mostly higher to start the second quarter ahead of expected tariff announcements from the Trump administration. Tesla (TSLA) and Rivian (RIVN) were among the leaders despite Tesla's sales plunge in France. Jefferies downgraded three of the four biggest airline stocks on the market, creating more downside action. Johnson & Johnson (JNJ) had its worst trading day in five years over bankruptcy woes. Caroline Woods takes investors through the session's biggest stories.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Healthcare headwinds have TheoTrade's Don Kaufman leaning bearish on Johnson & Johnson (JNJ) while staying bullish in GE Aerospace (GE) despite hitting 18-year highs today. He offers options trades in those companies alongside an earnings play for Lululemon (LULU). Kevin Green turns to the technical trends behind the charts.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

00:00 Recessão Econômica no Brasil em 2025 00:56 Governo Lula e a Crise na Economia Brasileira 01:35 A Estratégia do Governo Lula para Vencer 2026 03:05 Dólar R$ 7 03:15 Ibovespa Pode Subir Sem Parar 03:35 Carteira de Investimentos Renda Variável | Janeiro 2025 04:08 Ibovespa Vai Para o Fundo do Poço 04:25 Javier Milei e a Bolsa da Argentina 05:40 Renda Variável Pode Valorizar Muito 05:54 Ibovespa e IFIX 06:30 Selic 15,75% 07:00 Carteira de Investimentos Renda Fixa | Janeiro 2025 08:00 IPCA 08:20 Inflação Alimentos e Remédios 09:05 S&P 500 Bate Recorde 09:45 Netflix (NFLX) 10:08 Procter & Gamble (PG) 10:30 Johnson & Johnson (JNJ) 11:02 Carteira de Investimentos no Exterior | Janeiro 2025 11:36 Trump e Criptomoedas 12:02 Bitcoin 12:23 Carteira de Investimentos Criptomoedas | Janeiro 2025 12:54 Consultoria de Investimentos RC Wealth

Kevin Green joins Morning Movers to look at how President Trump's tariffs plan could impact several areas of the market, specifically currencies and copper. Then, the focus shifts to Trump's ambitious A.I. project with OpenAI's Sam Altman and Oracle's (ORCL) Larry Ellison. Finally, Kevin checks in on a pair of premarket earnings movers: Johnson & Johnson (JNJ) and Procter & Gamble (PG). ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

The SPX tapped its first all-time high of the year after hitting a string of records in the back half of 2024. However, the NDX saw the biggest rally after the Trump administration announced a $500 billion Stargate A.I. infrastructure plan. Seagate (STX) saw big green shoots after posting an earnings beat. Johnson & Johnson (JNJ) also beat but reported weaker-than-expected sales guidance for 2025. Caroline Woods looks at the day's biggest stories. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

In this episode of Dividend Talk, we sit down with Ryne Williams, a passionate dividend investor and YouTube content creator, to discuss his investing journey. Ryne shares how he got started, lessons learned, and the strategies that have helped him build his portfolio over the years. Tune in for an interesting conversation filled with investing wisdom and a few laughs along the way! Topics Discussed: Ryne's investing journey and how he got started Transition from growth stocks to dividend investing The role of patience and discipline in investing Balancing ETFs vs. individual stock picking The psychology of market trends and FOMO Interest rates and their impact on REITs and financial markets The future of consumer goods and snack companies Investing in tax-advantaged accounts Portfolio diversification strategies How social media and YouTube influence investing decisions Companies Discussed: Johnson & Johnson (JNJ), Bristol Myers Squibb (BMY), 3M (MMM), Bayer AG (BAYN.DE), Altria Group (MO), Realty Income (O),Main Street Capital (MAIN) ,Vici Properties (VICI) , PepsiCo (PEP) ,Coca-Cola (KO) ,Starbucks (SBUX) ,Visa (V) ,William Sonoma (WSM) ,Lowe's (LOW) ,Medtronic (MDT) ,Nike (NKE) ,Old Dominion Freight Line (ODFL) ,Zoetis (ZTS) ,Rollins (ROL) ,Walgreens Boots Alliance (WBA) ,Procter & Gamble (PG) ,DHL Group (DHL.DE) ,Fuchs Petrolub (FPE3.DE) ,Ahold Delhaize (AD.AS) Link / Resource: Book - What i learned about investing from darwin  Follow him here: https://www.youtube.com/@rynewilliams https://www.retirewithryne.com/

En este episodio, exploramos el reciente subsidio de $6.6B que el Departamento de Comercio de EE.UU. otorgó a TSMC ($TSM) para su expansión en Arizona, marcando un hito en la fabricación de semiconductores en suelo estadounidense. Hablamos de la nueva inversión de Nvidia ($NVDA) en Applied Digital ($APLD), reflejando su compromiso con el crecimiento de la infraestructura de IA. Además, Eli Lilly ($LLY) y Johnson & Johnson ($JNJ) desafían al gobierno de EE.UU. en la regulación del programa 340B. También revisamos el crecimiento de Alibaba ($BABA) en el segmento de nube y el impulso de sus plataformas de e-commerce, y analizamos la nueva jugada de Berkshire Hathaway al invertir en Domino's Pizza ($DPZ). ¡Sabor a movimientos estratégicos y tecnología en cada segmento!

En el episodio de hoy, analizamos el desempeño de McDonald's $MCD tras un informe de ganancias que sorprendió a la baja y cómo los mercados internacionales están impactando sus cifras. También exploramos la apuesta de Apple $AAPL en India, con exportaciones récord de iPhones, y el avance de Lithium Americas $LAC en la producción de litio en EE. UU. gracias a un préstamo de $2.26B del Departamento de Energía. Además, profundizamos en la disputa entre Microsoft $MSFT y Google $GOOG, y el conflicto de Johnson & Johnson $JNJ con el Departamento de Justicia por demandas de talco. ¡No te pierdas el análisis de estos movimientos clave en el mercado!

Welcome to Episode 217 of the Dividend Talk Podcast! In this episode, Derek and the European Dividend Growth Investor (EDGI) discuss their third-quarter dividend portfolio performance, recent stock purchases, and some key earnings reports. Timestamps 00:00 - Intro & Quick Market Recap 02:00 - ECB Rate Cuts & Impact on Mortgages 07:00 - Derek's €100K Milestone  10:30 - EDGI's Dividend Portfolio Grows by 29%!   16:00 - Recent Stock Purchases: Brookfield Asset Management (BAM) & BAE Systems (BA.L) 18:00 - Earnings Highlights: ASML (ASML), Johnson & Johnson (JNJ)   30:00 - Listener Questions     - Trading 212 Debit Card: Good for Dividend Investors?     - Taxes on Dividends in Belgium & Sweden     - Paddleball & Pickleball: Growing Sports, Growing Industries?   50:00 - Target (TGT), Diageo (DGE.L), Pernod Ricard (RI) Discussion   If you enjoy this episode, don't forget to like, subscribe, and hit the notification bell for more dividend growth investing content! --- Companies & Tickers Mentioned - ASR Nederland (ASRNL) - Paychex (PAYX) - Evolution Gaming (EVO) - Brookfield Asset Management (BAM) - BAE Systems (BA.L) - ASML Holding NV (ASML) - Johnson & Johnson (JNJ) - Target (TGT) - Diageo (DGE.L) - Pernod Ricard (RI) - Ahold Delhaize (AD.AS) Thanks for listening! Let us know your thoughts in the comments and feel free to ask any questions for future episode

Here's what is happening in the markets today, Wednesday July 17th - Dow Has Best Day in Over a Year, Hits All-Time High - Russell 2000 Jumps 3%, Marking 5 Days of Gains - Rotation Happening? Tech Giants Like Nvidia (NVDA) and Alphabet (GOOG) See Over 1% Losses - Bank of America Surges 5% After Better Than Expected Earnings - United Airlines (UAL), Discover Financial Services (DFS), Johnson & Johnson (JNJ), and U.S. Bancorp (USB) Set to Announce Earnings - Futures Indicates a 100% Chance of a Fed Rate Cut in September - Trump Will Respect Powell's Term if Elected - Five (FIVE) Below CEO Steps Down PLUS: How we trade these markets and our current positions This wraps up today's stock market news. If you enjoyed the "Stock Market Today" episode, make sure to subscribe to this podcast.  And for more stock market news,  visit our YouTube Channel: https://youtube.com/rockwelltrading2008 #todaysstockmarket #stockmarkettoday #stockmarket

Ma réaction suite à la chute des actions de Nike. Découvrez une nouvelle position que je rajoute à mon portefeuille. La différence entre le S&P 500 et le S&P500 Equal Weight. Trouver des opportunités d'achat dans un contexte où les indices boursiers sont à des sommets records. CORRECTION: Le segment des produits de consommation de base de Johnson&Johnson a été séparé dans une autre entreprise à part, nommée Kenvue, Inc. (KVUE). L'action de Johnson&Johnson (JNJ) ne concerne que les médicaments. Lien vers l'indice S&P500 Equal Weight: https://www.spglobal.com/spdji/en/indices/equity/sp-500-equal-weight-index/#overview Devenez un insider de la firme Traders 360: ⁠https://traders360.ca/product/infolettre-analyse-360/⁠ Suivez-moi sur Instagram & TikTok IG: alextraders360 TikTok: alexdemers360

Noticias Económicas y Financieras La forma en que los editores abordan la IA generativa está cambiando a medida que la industria de los medios evoluciona su perspectiva sobre las tecnologías del futuro. Inicialmente, las preguntas se habían centrado en cómo afectaría su fuerza laboral u operaciones, así como también en cómo podrían beneficiarse o verse perjudicados por los nuevos desarrollos. Algunas de esas respuestas ahora se están volviendo evidentes en muchas partes del espacio editorial, desde películas y música hasta contenido en línea y la palabra impresa. $NVDA Nvidia subió un 6% AH el miércoles, superando el nivel de 1.000 dólares, después de que el gigante de los semiconductores informara resultados trimestrales y orientaciones que superaron las expectativas de Wall Street. Eso no fue todo. El favorito de la IA anunció una división de acciones de 10 a 1, duplicó con creces su dividendo trimestral e impulsó al mercado con los futuros del Nasdaq subiendo un 1% en las operaciones nocturnas. "La próxima revolución industrial ha comenzado", declaró el director general, Jensen Huang. "Las empresas y los países se están asociando con Nvidia para cambiar los centros de datos tradicionales de billones de dólares a la computación acelerada para producir un nuevo producto: la inteligencia artificial". Con el objetivo de brindar más supervisión a este espacio de rápido crecimiento, la Oficina de Protección Financiera del Consumidor ha emitido una regla interpretativa que tratará a los prestamistas de "compre ahora, pague después" esencialmente de la misma manera que a los emisores de tarjetas de crédito. Los proveedores de BNPL como Affirm $AFRM, PayPal $PYPL y Block's $SQ Afterpay ahora deberán reembolsar los productos devueltos, investigar disputas comerciales y proporcionar facturas con información de tarifas. Las empresas de tarjetas de crédito actualmente cumplen con tales reglas bajo la Ley de Veracidad en los Préstamos, que existe desde hace décadas, pero la CFPB ha estado tomando medidas drásticas en este espacio, y más recientemente finalizó una regla para limitar los cargos por pagos atrasados ​​de las tarjetas de crédito. $DD DuPont se está uniendo a conglomerados en expansión como General Electric $GE y Johnson & Johnson $JNJ para dividir sus negocios en compañías más enfocadas. El gigante químico, que se formó en 1802, se separará en tres entidades que cotizan en bolsa, lo que hará que sus acciones suban aproximadamente un 5% en las operaciones previas a la comercialización. El director ejecutivo de DuPont, Ed Breen, dijo que el plan de separación desbloqueará un valor incremental para los accionistas y clientes, y anunció que la actual directora financiera, Lori Koch, lo sucederá en su puesto actual, a partir del 1 de junio. Breen pasará a ser presidente ejecutivo de tiempo completo. Actas de la Fed: los datos no aumentaron la confianza hacia el objetivo de inflación. $TGT Target cae tras señalar debilidad en el consumo discrecional. Anglo American rechaza nueva oferta de BHP, pero extiende plazo.

Here's what is happening in the markets today, Monday April 15th - Last week was the worst week of 2024 - S&P 500 and Nasdaq post consecutive losing weeks - In focus: tensions in Middle East after Iran attacks Israel - Gold lower after making record highs last week - Oil prices lower - Bitcoin plummets to $65,000  - This week: more earnings, e.g. Goldman Sachs (GS), Bank of America (BAC), Morgan Stanley (MS), Johnson & Johnson (JNJ), UnitedHealth (UNH), United Airlines (UAL) and  Netflix (NFLX) PLUS: How we trade these markets and our current positions This wraps up today's stock market news. If you enjoyed the "Stock Market Today" episode, make sure to subscribe to this podcast.  And for more stock market news,  visit our YouTube Channel: https://youtube.com/rockwelltrading2008 #todaysstockmarket #stockmarkettoday #stockmarket

It's back, front and centre, US quarterly earnings. Following the release on Friday of Q1 numbers from JP Morgan (JPM), Citigroup (C) and Wells Fargo (WFC), it's the turn this week of Goldman Sachs (GS), Bank of America (BAC), Johnson & Johnson (JNJ, Procter & Gamble (PG) and Netflix (NFLX) amongst others. Watchout out for all these as they all trade all session on the IG platform to enable clients to take advantage. Meanwhile in Europe LVMH (MC) and ASML (ASML) lead the charge. Economic data may also provide opportunities for FX traders with US retail sales, UK jobs data and inflation while in China a raft of data including Q1 GDP, retail sales and industrial production. The big question there is will it provide the authorities with enough evidence of the need for state support? Any opinion, news, research, analysis, or other information does not constitute investment or trading advice. Follow us on Twitter, Instagram, and YouTube 

Johnson & Johnson (JNJ) convened its earnings call on Tuesday, January 23rd, 2024, providing insights on the state of the company and the direction it hopes to take in the near future. Joaquin Duato, CEO of Johnson & Johnson, expressed contentment with the company's performance, particularly within their pulmonary franchise. "Overall, we're very happy with the trajectory of our pulmonary franchise in 2023. And we expect a similar trajectory as macitentan, OPSUMIT, and Tadalafil become standard of care", Duato stated during the earnings call. The year 2023 saw Johnson & Johnson report full-year sales of $85.2 billion, reflecting a growth rate of 7.4%. According to the earnings call, this performance was largely attributed to key products in their Innovative Medicine business such as DARZALEX, ERLEADA, STELARA, and TREMFYA, contributing substantially to the company's Oncology division. Following the recent launch of CARVYKTI, TECVAYLI, TALVEY, and SPRAVATO, Johnson & Johnson has broadened its scope in the oncology market. The firm also mentioned on the call that despite the ongoing recovery from the global pandemic, they marked notable increases in electrophysiology, heart recovery, surgery, orthopedics, and Vision, surpassing pre-pandemic levels in their MedTech business. Johnson & Johnson also shared its prospective plans and investment strategies. Acknowledged in the call, the company intends to allocate $15 billion towards research and development in 2023, underlining their commitment to innovation and pipeline advancement. In an effort to strengthen their oncology portfolio, JNJ plans to pursue strategic acquisitions, notably Ambrx, while simultaneously focusing on commercial execution, product differentiation, and expansion within the MedTech sector, as stated in the earnings call. The Johnson & Johnson earnings call highlighted steady financial performance and constant growth. With a focus on research and development, the company aims to introduce innovative products and engage in strategic acquisitions to support long-term growth and sustainability. As mentioned in the earnings call, amidst a competitive healthcare industry, the attributes that distinguish Johnson & Johnson are their emphasis on innovation and their dedication to meeting the evolving needs of patients globally. Remaining cautiously optimistic, it's important to note that these are plans based on the current circumstances and market trends, the actualization of which is dependent on a plethora of internal and external factors. JNJ Company info: https://finance.yahoo.com/quote/JNJ/profile For more PSFK research : www.psfk.com  This email has been published and shared for the purpose of business research and is not intended as investment advice.

ABD piyasalarına yönelik ekonomi haberleri, yani akşam bültenimiz yayında! Bugünkü bültenimizin menüsünde; Ray Dalio, Cathie Wood ve Bill Ackmann gibi ünlü yatırımcıların portföylerine yönelik güncel görünüm yer alıyor. Bu bölümümüzde adı geçen hisseler: Meta Platforms (#META), Microsoft (#MSFT), Amazon (#AMZN), Nvidia (#NVDA), Alphabet (#GOOGL), Uber Technologies (#UBER), Alibaba (#BABA), Advanced Micro Devices (#AMD), Intel (#INTC), FedEx (#FDX), Chipotle (#CMG), Restraurant Brands (#QSR), Hilton Hotels (#HLT), Lowe's Companies (#LOW), Howard Hughes Holdings (HHH), Canadian Pacific (#CP), Tesla (#TSLA), UiPath (#PATH), Coinbase Global (#COIN), Roku (#ROKU), Zoom Video Communications (#ZM), Block (#SQ), DraftKings (#DKNG), Exact Sciences (#EXAS), Twilio (#TWLO), Shopify (#SHOP), Procter & Gamble (#PG), Johnson & Johnson (#JNJ), Coca-Cola (#KO), PepsiCo (#PEP), Costco Wholesale (#COST), McDonald's (#MCD) ve Walmart (#WMT) Akşam bülteni serimizde bahsi geçen haberleri okumak isterseniz, getmidas.com/midasin-kulaklari adresindeki haberlerimize göz atabilirsiniz. Midas uygulamasını indir: https://app.getmidas.com/gmih/mie6gpeu Midas'ın Kulakları: https://www.getmidas.com/midasin-kulaklari Twitter: https://twitter.com/getmidas Instagram: https://www.instagram.com/get_midas/ Not: Bu içerik, içeriğin yayınlandığı günkü veriler ve haberler baz alınarak hazırlanmıştır. Eğer varsa içerikte geçen hedef fiyat tahminleri, uzman ve analist yorumları bu içeriğin yayınlandığı tarihte geçerlidir. Bu tahmin ve yorumlar zaman içinde değişkenlik gösterebilmektedir. Bu podcast'te yer alan haberler ve haberlerin içerdiği şirketler hakkındaki bilgiler yatırım danışmanlığı kapsamında değildir. Bahsi geçen hisselerdeki; hisse adı, fiyatı ve grafikleri de dahil temsilidir, yatırım tavsiyesi değildir.

Here's what is happening in the markets today, Tuesday, October 17th - Yesterday, all 3 indices closed higher - Today's major earnings: Johnson & Johnson (JNJ), United Airlines (UAL), Bank of America (BAC) and Goldman Sach (GS) - Retail Sales Report - here's what happened - Apple's (AAPL) CEO Tim Cook makes surprise visit in China - The reason behind Bitcoin's super strange move - Geopolitical concerns about Israel-Hamas war PLUS: How we trade these markets and our current positions This wraps up today's stock market news. If you enjoyed the "Stock Market Today" episode, make sure to subscribe to this podcast. And for more stock market news, visit our YouTube Channel: https://youtube.com/rockwelltrading2008 #todaysstockmarket #stockmarkettoday #stockmarket

In this episode, we're taking a look back at the infamous Tylenol murders, how Johnson & Johnson (JNJ) handled the situation, and some of the good that came of it. We'll also recap the stocks we bought and the dividends received too. **SPECIAL SEEKINGALPHA.COM offer - Try Seeking Alpha's Premium for $239/year with a 14-day free trial. Use this affiliate link and I'll get a few bucks kicked back my way at no additional cost to you. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠CLICK HERE ⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get my FREE 48-page eBook "Brief Thoughts on Life, Love & Investing" and FREE weekly newsletter ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠! Check out my portfolios ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠thedividendtracker.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (affiliate link) The Essays of Warren Buffett ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BOOK LINK⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Get cash back on your gas, with the UPSIDE APP. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠CLICK HERE!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Contact - russ@dapperdividends.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Alphaspread.com affiliate link⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ = where I show intrinsic values on the channel. Follow Russ on X - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@Rustyram78⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Remember this is not financial advice and it's ultimately your money and responsibility! --- Support this podcast: https://podcasters.spotify.com/pod/show/dapper-dividends/support

This is a deep dive into 10 years of financial data for Johnson & Johnson ($JNJ). Strong Dividend, Stock Buy Backs, Growing Earnings and Revenue. The stock returned over 200% in the last 10 years, when should be buy this stock to make another 200%? "Long ago, Ben Graham taught me that 'Price is what you pay; value is what you get.' Whether we're talking about socks or stocks, I like buying quality merchandise when it is marked down." - Warren Buffett Don't forget to Like this video and SUBSCRIBE for weekly stock reviews!

Here's what is happening in the markets today, Thursday, July 20th Blue Chips get stronger and Tech weakens DOW has its best win streak since 2019 Earnings still in the spotlight TSLA plans to shut down factories NFLX gets hammered Johnson & Johnson (JNJ) soars! PLUS: Can I sell calls against my PNC Shares? This wraps up today's stock market news. If you enjoyed the "Stock Market Today" episode, make sure to subscribe to this podcast. And for more stock market news, visit our YouTube Channel: https://youtube.com/rockwelltrading2008 #todaysstockmarket #stockmarkettoday #stockmarket

In this episode, we discuss dividend hikes and cuts from Johnson & Johnson ($JNJ), Costco ($COST), Sonoco ($SON) and Blackstone ($BX) We also discuss the recent earnings results from 1. Johnson & Johnson 2. ASML 3. Blackstone 4. Snap on and European DGIs favourite IBM We check out the portfolio of a fellow Facebook member before answering questions from the community.

Healthy free cash flow has enabled Johnson & Johnson (JNJ) to increase its dividend over the past half century, notes Lee Bohl. He and Damien Conover discuss takeaways from JNJ earnings. JNJ's 1Q worldwide pharmaceutical sales came in at $13.41B and its 1Q revenue came in at $24.75B versus an estimated $23.57B. They also go over other stocks to keep on your radar. Tune in to find out more about the stock market today.

Goldman Sachs (GS) is always one to watch, not just because it's in the Dow, but technically right now it's a very interesting pivot point, notes Jay Woods. He discusses stocks to watch this week for earnings. He talks about key earnings this week which include Goldman Sachs (GS), Johnson & Johnson (JNJ), Netflix (NFLX), and Tesla (TSLA). He then goes over potential market impact of another Fed hike, in addition to the takeaways from recent market performance. Tune in to find out more about the stock market today.

In this episode, we revisit our interview with Bill Facteau, who is Chairman, President, and CEO of Earlens Corporation in Menlo Park, California.  Bill joined Earlens Corporation as Chairman, President & CEO in November of 2013. Bill was at Johnson and Johnson (JNJ)as the Worldwide President of their ENT Division. Facteau joined JNJ via the $800M acquisition of Acclarent, Inc., where he served as the President, and CEO since its formation in 2004.

Semiconductor stocks are under pressure after China issues a complaint. Renita Young discusses this as China's commerce ministry says that Japan is "obstructing chip industry cooperation." Nvidia (NVDA), AMD (AMD), Intel (INTC) are all lower in the premarket. She also talks about how Johnson & Johnson (JNJ) has to pay $9.8B to resolve talc claims which is payable over 25 years. JNJ subsidiary LTL Management re-filed for Chapter 11 bankruptcy. Tune in to find out more about the stock market today.

Dow Jones today finished in the red along with S&P 500 Index or SPX, Nasdaq-100, and Russell 2000. Next, Renita Young weighs in on Berenberg cutting the Tesla (TSLA) price target to $200 from $255, while upgrading the stock to buy from hold. TSLA stock price today was down over 6%. Ford Motor Co. (F) cut the price of the Mustang Mach-E. Court rejected a bankruptcy plan for Johnson & Johnson (JNJ) talc lawsuits. On the positive side, SoFi Technologies (SOFI) stock surged after earnings.

Johnson & Johnson (JNJ), Procter & Gamble (PG) and McDonald's (MCD) are three dividend aristocrats, and I just SOLD them! If you'd like to jump to why, it starts at about 18:00. Dividend Stock Overlap SPREADSHEET Chris Pronger's heart-stopping hockey puck HERE Get my FREE 48-page eBook "Brief Thoughts on Life, Love & Investing" and weekly newsletter HERE! See Russ in action at his job doing some WELDING! Get cash back on your gas, with the UPSIDE APP. CLICK HERE! Contact - russ@dapperdividends.com **SPECIAL SEEKINGALPHA.COM offer - $99 for the annual plan. Use this affiliate link and I'll get a few bucks kicked back my way at no additional cost to you- CLICK HERE! WallStreetSurvivor.com "Is Seeking Alpha Worth It?" Alphaspread.com affiliate link = where I show intrinsic values on the channel. I highly recommend this book for ALL interested in dividend investing, from beginner to advanced - "The Dividend Millionaire" book (The above links are an affiliation where I will receive a small commission at no additional charge to you.) Check my website out - https://dapperdividends.com/ Follow Russ on Twitter - @Rustyram78 Remember this is not financial advice and it's ultimately your money and your responsibility!

Here's what is happening in the markets today, Tuesday, October 18th Nasdaq rallies more than 3% Can stocks climb another 10%? Natural Gas and Crude Oil moving lower This week: Earnings season kicks into gear: More than 60 companies are reporting, e.g. Goldman Sachs (GS), Procter & Gamble (PG), Bank of America (BAC), Tesla (TSLA), Netflix (NFLX), United Airlines (UAL) and Johnson & Johnson (JNJ) … and much more PLUS: How we trade these markets and our current positions This wraps up today's stock market news. If you enjoyed the "Stock Market Today" episode, make sure to subscribe to this podcast. And for more stock market news, visit our YouTube Channel: https://youtube.com/rockwelltrading2008 #todaysstockmarket #stockmarkettoday #stockmarket

Here's what is happening in the markets today, Monday, October 17th Last week was crazy volatile S&P 500 and the Nasdaq had another losing week Consumer survey from the University of Michigan showed inflation expectations are increasing Crude oil prices are falling Interest rates are higher again This week: Earnings season kicks into gear: More than 60 companies are reporting, e.g. Goldman Sachs (GS), Procter & Gamble (PG), Bank of America (BAC), Tesla (TSLA), Netflix (NFLX), United Airlines (UAL) and Johnson & Johnson (JNJ) … and much more PLUS: How we trade these markets and our current positions This wraps up today's stock market news. If you enjoyed the "Stock Market Today" episode, make sure to subscribe to this podcast. And for more stock market news, visit our YouTube Channel: https://youtube.com/rockwelltrading2008 #todaysstockmarket #stockmarkettoday #stockmarket

Let's understand the business from a company that is on a mission to improve access and affordability, create healthier communities, and put a healthy mind, body, and environment within reach of everyone, everywhere.Chapters:(00:00) Intro (00:19) Business Description(01:53) Industry Landscape(04:44) Annual Financial PerformanceIndustry: Drug Manufacturers—General

En este episodio hablaremos de los eventos más relevantes relacionados a los mercados financieros de Estados Unidos en la semana laboral que terminó el viernes 30 de Septiembre de 2022 En la idea de la semana hablaremos de Johnson and Johnson (JNJ) (04:56) Y en la sección educativa vamos a hablar sobre Opciones tipo Call (08:38) Les dejo la liga del blog donde estaremos subiendo las transcripciones de los episodios: invertirenlabolsa.substack.com

On today's episode, meet Rita Ribeiro. Rita is a bi-lingual leader with broad multi-cultural and health equity experience. She is currently the Product Director, Lung at The Janssen Pharmaceutical Companies of Johnson & Johnson (JNJ). Before joining JNJ, Rita held multiple roles in Sales and marketing at Boehringer Ingelheim Pharmaceuticals, Abbott Diagnostics and Bristol Myers Squibb company. Rita has a bachelor's degree in Management from Pace University, a Master's in Business Administration in Marketing Management from Pace Lubin School of Business and a Strategic Marketing Certificate from Columbia University in New York. She holds leadership roles with community not-for profit organizations including president of the board of directors of the United Way of greater Mercer County, the first Latina to hold the position. Her non-profit work is focused on community health, economic development, and gender parity.

Large cap pharmas continue to be defensive and are trading better than other stocks today, says Marshall Gordon. He discusses investing in the healthcare sector, highlighting the Health Care Select Sector SPDR Fund (XLV) which hit a 52-week low today. He also talks about his stock to watch, Pfizer (PFE) which he compares to other Covid-19 vaccine stocks such as Moderna (MRNA), Johnson & Johnson (JNJ), and AstraZeneca (AZN). Tune in to find out more.

GESTIONNAIRES EN ACTION. L'épicier et pharmacien Metro (MRU, 70,27$) a dévoilé des résultats financiers relativement conformes aux prévisions au second trimestre de son exercice 2022, terminé le 12 mars, malgré des contraintes liées au variant Omicron et à la hausse de l'inflation, ainsi qu'à des problèmes de pénurie de main-d'oeuvre et de chaîne d'approvisionnement. Luc Girard, gestionnaire de portefeuille chez Noël Girard Lehoux Valeurs mobilières Desjardins, estime que l'entreprise a dévoilé de bons résultats dans les circonstances, mais que l'action est bien évaluée en ce moment, ce qui fait que l'entreprise devra vraiment surprendre les marchés pour qu'elle poursuive sa progression. Ce dernier a également commenté le dossier Netflix (NFLX, 218,22$US), qui a vu sa capitalisation boursière chuter de près de 55 milliards de dollars américains dans la seule séance du 20 avril après avoir dévoilé qu'elle avait perdu 203 000 abonnés durant le premier trimestre de 2022. À son avis, la réaction des marchés n'a pas été exagérée et le plongeon de 35% du titre le 20 avril était justifié, encore une fois pour des questions de valorisation. À son avis, le plongeon de 67% du titre de Netflix depuis son sommet de 700$US atteint en novembre dernier ne signifie pas encore la fin de la domination des FAANG à New York, bien que les titres qui composent l'acronyme (Meta Platforms (Facebook, FB, 188,07$US), Amazon (AMZN, 2 965,92$US), Apple (APPL, 166,42$US), Netflix et Alphabet (Google, GOOGL, 2 504,60$US) aient été sous pression récemment. Il compare la situation des FAANG à celle des Nifty Fifthy dans les années 1960-70, qui incluaient à l'époque des entreprises comme Polaroid, Avon et Johnson & Johnson (JNJ, 183,36$US) Luc Girard a de plus commenté les très bons résultats financiers du fabricant de voitures électriques Tesla (TSLA, 1008,78$US), estimant que le titre est aussi valorisé pour la perfection. Pour de l'information concernant l'utilisation de vos données personnelles - https://omnystudio.com/policies/listener/fr

Netflix (NFLX) share price drops 25 percent. Johnson & Johnson (JNJ) beats Q1 estimates, but reports weak demand for its Covid-19 vaccine. Ramsay Health Care (RHC) says it's received a takeover bid from a consortium led by KKR & Co (KKR), if it goes through it could be the biggest overseas private equity purchase in Australian history. www.sharesies.com For more share market news, subscribe to Lunch Money, Sharesies' bite-sized email update: https://www.sharesies.nz/lunch-money If you'd like to get in touch, for any reason at all, email recap@sharesies.co.nz or record a voice message: https://anchor.fm/sharesies2/message. Investing involves risk. You aren't guaranteed to make money, and you might lose the money you start with. We don't provide personalised advice or recommendations. Any information we provide is general only and current at the time. For specific advice, speak to a licensed financial advice provider.

"My base case remains that a recession this year is a low probability given continued pent-up demand, strong labor market, and strong corporate profits," states Hank Smith. Currently, he likes the healthcare sector as both a defensive and a reopening play. Smith provides his healthcare stocks to watch, which include Johnson & Johnson (JNJ) and Pfizer (PFE).

Johnson & Johnson (JNJ) sees sales growth across its pharmaceuticals and medical device businesses. Supply chain and inflation affect General Electric's (GE) healthcare and wind generation wings. Microsoft (MSFT) increases revenue by 20 percent boosted by its PC and cloud businesses. www.sharesies.com For more share market news, subscribe to Lunch Money, Sharesies' bite-sized email update: https://www.sharesies.nz/lunch-money If you'd like to get in touch, for any reason at all, email recap@sharesies.co.nz or record a voice message: https://anchor.fm/sharesies2/message. Investing involves risk. You aren't guaranteed to make money, and you might lose the money you start with. We don't provide personalised advice or recommendations. Any information we provide is general only and current at the time. For specific advice, speak to a licensed financial advice provider

On today's episode, meet Rodney Gillespie. Rodney is a Global executive with broad leadership experience. He is currently the Vice President, Oncology Sales & Marketing, Solid Tumor at The Janssen Pharmaceutical Companies of Johnson & Johnson (JNJ). Before joining JNJ, Rodney had a thirteen-year tenure with AstraZeneca, including stints in the UK and in South Africa. Rodney has a Bachelor of Science Degree in Commerce & Engineering from Drexel University in Philadelphia and a Masters of Business Administration from University of Washington in Seattle. He has a passion for participating in activities and organizations that allow him to give back to disadvantaged communities and kids.

Simon discusses how pessimism is dominating the headlines, but overall there are more tailwinds than headwinds. He details why stock investors should still be optimistic about 2022. He also highlights the buy rationale for Visa (V), Disney (DIS), and Johnson and Johnson (JNJ).

Healthcare giant Johnson & Johnson (JNJ) announces it will split into two separate companies. Warby Parker (WRBY) reports revenue growth in its first lot of financials as a publicly-listed company. Good Spirits Hospitality (GSH) agrees to acquire Nourish Group—the owner of popular hospitality venues including Soul Bar & Bistro and Jervois Steak House. www.sharesies.com For more share market news, subscribe to Lunch Money, Sharesies' bite-sized email update: https://www.sharesies.nz/lunch-money If you'd like to get in touch, for any reason at all, email recap@sharesies.co.nz or record a voice message: https://anchor.fm/sharesies2/message. Investing involves risk. You aren't guaranteed to make money, and you might lose the money you start with. We don't provide personalised advice or recommendations. Any information we provide is general only and current at the time. For specific advice, speak to a licensed financial advice provider

This week we talk about the spin offs relating to Johnson & Johnson ($JNJ) and GE ($GE). We also talk about the last of the earnings from ETR:SIE, AMS: AD, ETR: ALV Related Links When to Buy JNJ - https://www.youtube.com/watch?v=WJ9lpAghMxs Drip Investing - https://www.dripinvesting.org Allianz - https://europeandgi.com/review/allianz-share-price-drop-explained/

Simon cautions on judging an investment by the knee-jerk, post-earnings market reaction. He also discusses the potential pitfalls of trying to predict legislative outcomes, underappreciating "slow" risk, and the limitations of the widely-adopted "60/40" portfolio allocation. He highlights quarterly results from Johnson and Johnson (JNJ), AbbVie (ABBV), Merck (MRK), Amazon (AMZN), Northrop Grumman (NOC), and L3Harris Technologies (LHX).

Johnson & Johnson (JNJ), UnitedHealth (UNH), Thermo Fisher Scientific (TMO), Pfizer (PFE), and Abbott (ABT) stocks are among the XLV ETF's top holdings. Cinthia Murphy weighs in on why Pfizer's big news was not all good news for healthcare ETFs. Additionally, she says that all healthcare ETFs combined have $5B year-to-date in inflows. Top healthcare ETF flows include XLV, XBI, and VHT.

Apple (AAPL), Microsoft (MSFT), Alphabet (GOOGL), Amazon (AMZN), Facebook (FB), Tesla (TSLA), Nvidia (NVDA), Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Walmart (WMT) stocks are among XOUT Capital's top holdings. David Barse weighs in the ETF's performance and provides an outlook for XOUT Capital's third quarter rebalance strategy.

What a tech company looks like when acquisitions are central to its business model. Progress Software CEO Yogesh Gupta (PRGS) explains his M&A mindset. Johnson & Johnson (JNJ) reports relatively COVID sales -- we'll tell you why that doesn't matter. Online insurance marketplace EverQuote (EVER) struggles with challenges in the auto insurance market. Canadian National Railway (CNI) responds to activist investors. The Drill Down with Cory Johnson offers a daily look at the business stories behind stocks on the move. Learn more about your ad choices. Visit megaphone.fm/adchoices

All major indices are up this week with Russell 2000 leading the way. Banks like JPMorgan Chase (JPM), Goldman Sachs (GS), Morgan Stanley (MS), Bank Of America (BAC), Wells Fargo (WFC), and Citigroup (C) kicked off the earnings season with mostly positive results. Also, FOMC minutes around inflation and tapering were released. Crude Oil is up 2% for the week and reached 7-year all-time-highs. Finally, Tom White and Ben Lichtenstein discuss crypto as bitcoin climbs on news of potential ETF approval. Major upcoming earnings for next week include Johnson & Johnson (JNJ), Procter & Gamble (PG), Netflix (NFLX), United Airlines (UAL), Verizon (VZ), Tesla (TSLA), AT&T (T), American Airlines (AAL), Southwest Airlines (LUV), Snap Inc. (SNAP), Intel (INTC), and American Express (AXP).

Pfizer (PFE) is on track to generate strong revenue and operating cash flow in 2021, with a large contribution from its Covid-19 vaccine, says David Toung, Senior Analyst of Medical Devices and Healthcare Services at Argus Research. He, and Sel Hardy, Equity Analyst at CFRA Research discuss the outlook for health care stocks. CFRA has a strong buy rating on Pfizer with a $57 price target and a buy rating on Johnson & Johnson (JNJ) with a $189 price target. Tune in to find out more.

Joanne Vanak has over 44 years of oncology nursing experience with a focus on research, treatment modalities, patient care, and education. Joanne is recently retired after a 22-year career with Janssen Pharmaceuticals, a Johnson and Johnson (JNJ) family company.Joanne spent the last years of her career at JNJ, leading a team of nurses and pharmacists within the Oncology Early Development Research and Development department.   Prior to this role, Joanne spent 9 years as a Senior Director in Scientific Advocacy, creating the position after recognizing an unmet need.  She developed the role, establishing key strategies to enhance relationships with over 30 oncology advocacy groups; working to identify patient needs, challenges, and create ideal methods of promoting patient advocacy.  She is credited with development of the Advocacy Connector, a web-based resource that identifies and promotes the advocacy groups and resources for patients, caregivers, and families, in a user-friendly fashion.  Joanne built an Oncology Medical Science Liaison (MSL) group; starting with 3 core members and eventually hiring, developing, and managing over 30+ people in the role of MSL. She developed a Nursing Innovation Council of Excellence Employee Resource Group (NICE ERG) within JNJ; gathering over 340 nurses and health care providers to share expertise and insights to multi-disciplinary functions, including sales and marketing teams in preparation for drug launches and new FDA approved indications. Prior to joining industry in 1998, Joanne worked as a Clinical Nurse Specialist (CNS) for over 25 years at a number of institutions including 3 large comprehensive cancer centers.  She has experience as an in-patient and out-patient registered nurse, and hospice nurse, focusing on patient care, nursing care, and education.   Among her accolades, Joanne was a finalist as “Nurse of Year” while practicing as a staff nurse at Georgetown University Medical Center in Washington, D.C. in 1991. Joanne is dedicated to the quality of care for cancer patients, caregivers, and families, as well as to the growth and expansion of oncology nursing as a profession.  She is a member of Advanced Practitioner Society for Hematology and Oncology (APSHO), a member of the DEI committee, and the SHAPE Partner organization.  Joanne is an active member of the Coast Guard Spouse Club as well. Joanne holds a Master of Science in Nursing from Georgetown University as well as a Bachelor of Science in Nursing from George Mason University.  .  Click the link to learn more about the Nurse Wellness Mentorship2. Download your FREE Mindfulness E-Book at stressblueprint.com/353. Follow the Nurse Wellness Podcast on Facebook and Instagram4. Join the Nurse Wellness Hub on Facebook  5. Email Nurse Wellness Podcast at hello@stressblueprint.com6. Background music produced by DNMbeats

Olá. Investidores! No Morning Call de hoje, 25 de agosto, os analistas Bruno Benassi e Nelly Colnaghi irão comentar sobre os seguintes assuntos: Nesta terça-feira (24), o Banco do Brasil (BBAS3) anunciou que irá destinar 10,5 bilhões de reais para financiamentos destinados ao agronegócio na safra 2021/2022. O objetivo do banco é atender a demanda do setor que está aquecido e apoiar produtores impactados pelas geadas de julho. A Porto Seguro é hoje uma das marcas mais conhecidas do país, porém o número de clientes não é compatível com o conhecimento da marca. Visto que a frota de veículos no Brasil, muito dificilmente dobrará de tamanho nos próximos 5 anos, a Porto tem focado em outros negócios. Segundo Guilherme Benchimol, presidente do Conselho de Administração da XP (NASDAQ:XP), a corretora deve alcançar sua meta de 1 trilhão de reais sob custódia ainda neste ano. O objetivo da empresa é chegar a 50 milhões de clientes nos próximos anos à medida que avança em novas frentes de negócios, ampliando a meta anterior de 15 milhões de clientes. Tendo finalmente resolvido o imbróglio relacionado a venda de suas térmicas a carvão, com a venda destas quase concretizadas, a Engie avança na expansão do seu portfólio de renováveis. A expectativa é que a companhia supere a marca de 1 gigawatt (GW) em usinas eólicas até setembro. A Johnson & Johnson (JNJ) comunicou nesta quarta-feira (25), antes da abertura dos mercados, que uma dose de reforço de sua vacina Covid-19 gerou uma resposta imunológica promissora em testes clínicos em estágio inicial. Para saber mais sobre as informações Confira o Morning Call de hoje!

Dave Nadig, Director of Research at ETF Trends, discusses the impact of the delta variant on labor force recovery. He talks about health care stocks, including Johnson & Johnson (JNJ), UnitedHealth Group (UNH), Merk (MRK), Pfizer (PFE), and Abbott Laboratories (ABT), as well as big bank stocks Bank of America (BAC), CitiGroup (C), JPMorgan Chase (JPM), Goldman Sachs (GS), and Wells Fargo (WFC). He also mentions Proshares Trust Long Online SHRT ETF (CLIX). Tune in to find out more.

05:15 Carteira Atualizada De Ações E ETFs Avenue Securities 07:48 Carteira Atualizada De Moedas Digitais 09:33 Rentabilidade Da Carteira De Ações E ETFs 19:50 Solta O Dedo No Like E Se Inscreve No Canal! 20:50 Planilha De Rentabilidade Da Carteira De Ações Americanas E ETFs 24:08 Gráfico Da Composição Da Carteira De Ações Americanas E ETFs 28:46 Rendimentos Em Dólares (Dividendos) Recebidos Em 2021 31:22 Análise Da Nike (NKE) 36:01 Análise Da Paychex (PAYX) 39:03 Análise Da Johnson & Johnson (JNJ) 42:27 Análise Da Procter & Gamble (PG) 43:00 Análise Da Aflac (AFL) 44:40 Análise Da Moodys (MCO) 45:41 Análise Da Disney (DIS) 46:00 Análise Da Visa (V) 47:00 Análise Da Monster (MNST) 47:24 Análise Da Rollins (ROL) 49:26 Pare De Ler Jornais E Sites Todos Os Dias! 51:11 Curso 100% Digital E Gratuito Sobre Investimentos 51:40 Ações Com Lucro: Devo Garantir O Lucro E Vender? 54:28 Ação Com Rentabilidade Alta: Devo Comprar Mais Dela? 58:46 As Únicas Duas Coisas Que Estão Sob Nosso Controle 01:01:53 Como Acompanhar As Informações Das Empresas? 01:04:55 Quais São Os Custos Para Investir No Exterior? 01:09:00 Como Funcionam As ETFs De Renda Fixa? 01:12:59 Vale A Pena Ter Maior Percentual Nos EUA Ou No Brasil? 01:16:55 Precisa Ter Muito Dinheiro Para Investir Na Avenue Securities? 01:19:33 Estratégias Para O Imposto De Herança Nos EUA 01:23:08 Investir 100% Nos EUA É Uma Boa Estratégia? 01:25:20 Como Analisar As Dívidas De Uma Empresa? 01:30:11 O Que Vale Mais A Pena: Investi Em Ações Ou ETFs? 01:31:37 Vale A Pena Começar A Investir Nos EUA Por ETFs? 01:33:21 Minha Opinião Sobre A Política Brasileira

Meridian Energy (MEL) and Contact Energy (CEN), two of New Zealand's largest electricity generators, seek partners to develop a green hydrogen power plant in Southland. ASX-listed mining company BHP Group (BHP) announces a nickel supply agreement with Tesla (TSLA). Johnson & Johnson (JNJ) releases its second quarter earnings. Recap is made for you, by Sharesies. www.sharesies.com For more share market news, subscribe to Lunch Money, Sharesies' bite-sized email update: https://www.sharesies.nz/lunch-money Investing involves risk. You aren't guaranteed to make money, and you might lose the money you start with. We don't provide personalised advice or recommendations. Any information we provide is general only and current at the time.

Free Boot Camp from Benzinga: Don't forget to register to Benzinga Boot Camp this Saturday 7/24 at https://www.benzinga.com/events/boot-camp/ Subscribe to all Benzinga Podcasts at https://www.benzinga.com/podcasts On Today's PreMarket Prep: - Netflix Earnings Reaction $NFLX - Bitcoin has an up day! - Earnings from Johnson & Johnson $JNJ, Chipotle $CMG, and Sleep Number $SNBR FEATURED GUEST: Gunnar Cuevas, CEO and Co-Founder at CARL MEET THE HOSTS: Dennis Dick Twitter: https://twitter.com/TripleDTrader Joel Elconin Twitter: https://twitter.com/Spus https://www.premarketprep.com/ Spencer Israel Twitter: https://twitter.com/sjisrael

Free Boot Camp from Benzinga: Don't forget to register to Benzinga Boot Camp this Saturday 7/24 at https://www.benzinga.com/events/boot-camp/ Subscribe to all Benzinga Podcasts at https://www.benzinga.com/podcasts On Today's PreMarket Prep: - Netflix Earnings Reaction $NFLX - Bitcoin has an up day! - Earnings from Johnson & Johnson $JNJ, Chipotle $CMG, and Sleep Number $SNBR FEATURED GUEST: Nate Tobik, Investor and Founder of CompleteBankData.com, author of The Bank Investor's Handbook MEET THE HOSTS: Dennis Dick Twitter: https://twitter.com/TripleDTrader Joel Elconin Twitter: https://twitter.com/Spus https://www.premarketprep.com/ Spencer Israel Twitter: https://twitter.com/sjisrael

- Earnings still in the spotlight this week. According to FactSet, about 85% of the S&P companies that have reported earnings have beaten estimates.- Netflix (NFLX) down slightly in pre-market trading after earnings miss. Reported $2.97EPS vs. $3.16 est. Rev and membership growth beat forecasts.- Coca-Cola (KO) up 2.0% pre-market after an earnings beat helped out by venues reopening like stadiums and theaters. Rev beat and raised full-year forecast.- Verizon (VZ) up 1.0%+ pre-market after an earnings beat. $1.37EPS vs. $1.30 est. and better revenue and subscriber growth. Also raised full-year outlook.- Johnson & Johnson (JNJ) up 1.0% pre-market after better than expected earnings. $2.48EPS vs $2.27 est. with better revenue and raised outlook after strong drug and medical device sales. But concerns mount over its effectiveness against the delta variant after a NYU study suggests that people who got the J&J vaccine get a second shot of it or a booster of the Pfizer or Moderna vaccines.- Harley-Davidson (HOG) up 2.5% pre-market after reporting $1.33EPS vs. $1.17 est. But rev was short of expectations.- Chipotle (CMG) up 4.5% pre-market after reporting $7.46EPS vs. $6.52 est. Rev was slightly better but overall nice earnings with indoor dining rebounding.- United (UAL) up 1.0% pre-market after reporting losses in-line with expectations (-$3.91 loss per share). Rev did beat forecast and was up 4x from previous year. However, sales still down 50% from 2019 levels.

- Travelers (TRV) up slightly pre-market after big earnings beat with $3.45 EPS vs. $2.39 est. Rev better than expected helped out by higher premiums, improved investment returns and lower catastrophic losses.- Halliburton (HAL) up 3.0%+ pre-market after better than expected earnings. EPS of $0.26, 3 cents better than expected. Reported 2nd q of profits with rebounding oil prices.- IBM (IBM) jumps 3.0%+ pre-market after better than expected $2.33 EPS better by 0.04 but also a rev beat. Rev up 3.4% from year earlier was best in 3 years. Cloud and software business big rev driver.- PPG Industries (PPG) missed earnings estimates with $1.94EPS vs a $2.19 est. Rev slightly better but warned that costs would increase during the current quarter.- Nasdaq (NDAQ) - up 1.0% pre-market after announcing that it will spin its platform for private company shares into a separate company. Sounds like the plan is in partnership with Citigroup, Morgan Stanley, and Goldman Sachs- 10 year yields keep falling, now below 1.2% for the first time since Feb. Falling yields and falling market- Jeff Bezos heading to space. The Blue Origin crew preparing to board the capsule. Bezo's is accompanied by his brother, female aviation pioneer Wally Funk and an 18 year Oliver Daemen who is filling in for the $28 mil charity auction winner. Scheduled for 9:00am ET. According to Morgan Stanley, Space market is expected to triple in size with more than 1Tril in annual sales by 2040.- Johnson & Johnson (JNJ), McKesson Corp (MCK), Cardinal Health (CAH), AmerisourceBergen (ABC) expected to announce a $26 bill opioid settlement. Settlement would involve payments from J&J the drugmaker and the 3 drug distributors.

- CPI Data increased 0.9% in June, the largest 1 month increase since June 2008- Traders turn their focus towards earnings.- Goldman Sachs (GS) higher pre-market have better than expected earnings and revenue.- JP Morgan Chase (JPM) down pre-market in spite of an earnings beat and better revenue.- PepsiCo (PEP) reported an earnings beat with revenue up 20%+ with restaurant demand returning- Boeing (BA) down pre-market after cutting production for its 787 Dreamline- Johnson & Johnson (JNJ) adding a warning label to the JNJ vaccine warning of a small incidence of Guillain-Barre syndrome

One mistake investors make is investing in things or companies that are overly complex, says Ken Van Leeuwen, Managing Director at Van Leeuwen & Company. He discusses other common mistakes investors make. He also gives some tips on how to invest for example, invest in what you know; look first at the company you work for. He then talks about his stock picks which include Johnson & Johnson (JNJ), Apple (AAPL), and Ross Stores (ROST).

In this episode, we talk with JOE HART, who is the President & CEO of Dale Carnegie Training, an organization whose founder pioneered the human performance movement over 100 years ago and has continued to succeed and grow worldwide, through constant research and innovation through foundational principles.THOUGHT #1Our Thoughts Make Us What We Are; Our Mental Attitude is the X-Factor that Determines Our FateTHOUGHT #2Ability is What You're Capable of Doing. Motivation Determines What You Do. Attitude Determines How Well You Do It. - Lou HoltzCONNECT:Website: DaleCarnegie.comPodcast: Take CommandFacebook: Dale Carnegie TrainingInstagram: JosephKHartInstagram - @DaleCarnegieTrainingLinkedin: Joseph K HartLinkedIn - Dale Carnegie TrainingTwitter: @JosephKHartTwitter- @DaleCarnegie YouTube: Dale CarnegieBRAND & RESOURCE MENTIONS:"Hero" (Enrique Iglesias) - Youtube.comThe Count - Muppets.Fandom.comPopeyes - Popeyes.com Chick-Fil-A - Chick-Fil-A.comAsset Health - Corporate.AssetHealth.comDale Carnegie (How To Win Friends& Influence People) - Amazon.comFortune 500 - Fortune.comMariah Suddarth - Linkedin.comRalph Waldo Emerson - Poets.org"Life is what our thoughts make it" - Goodreads.com80/20 rule- Investopedia.comKitsune - MyModernMet.comNormal Vincent Peel (The Power of Positive Thinking) - Amazon.comSteven Covey - FranklinCovey.comLou Holtz - Wikipedia.orgWarren Buffett - Wikipedia.orgNotre Dame Football - UND.comJohn Wooden - CoachWooden.comBoeing - Boeing.comFord - Ford.comAlex Gorsky (Johnson and Johnson) - JNJ.comBlack Sheep Assessment - worksheet.FindYourBlackSheep.comHard Rock International – HardRock.combookstarPR - bookstarPR.comThoughts That Rock – ThoughtsThatRock.comCertified Rock Star - CertifiedRockStar.comLeadership That Rocks: Take Your Brand's Culture to Eleven and Amp Up Results (Jim Knight) - LeadershipThatRocksBook.comCulture That Rocks: How to Revolutionize Your Company's Culture (Jim Knight) – CultureThatRocks.comBlack Sheep: Unleash the Extraordinary, Awe-Inspiring, Undiscovered You (Brant Menswar) - FindYourBlackSheep.comRock ‘n Roll With It: Overcoming the Challenge of Change (Brant Menswar) – RocknRollWithIt.comCannonball Kids' cancer – CannonballKidscancer.orgBig Kettle Drum - BigKettleDrum.comSpectacle Photography (Show/Website Photos) – SpectaclePhoto.comJeffrey Todd “JT” Keel (Show Music) - JT KeelJOE HART'S BIO: Joe Hart is the President and CEO of Dale Carnegie Training, an organization whose founder pioneered the human performance movement over 100 years ago and has continued to succeed and grow worldwide, through constant research and innovation building on its founding principles. Dale Carnegie Training has more than 3,000 trainers and consultants, operating in 200 offices in 86 countries impacting organizations, teams and individuals. Dale Carnegie Training's client list includes more than 400 of the Fortune Global 500, tens of thousands of small to mid-sized organizations and over 8 million individuals across the globe. In addition to being a Dale Carnegie graduate, Hart worked closely with the company as a strategic partner for nearly 10 years before taking the reins as President and CEO in 2015. He attributes much of his success in business to the Dale Carnegie training he had early in his career. A visionary, risk-taking leader, Hart helped build two technology-based companies, including an e-learning business called InfoAlly. In 2005, Joe sold that company and became the President of a new company called Asset Health. Asset Health is a privately-held and fast-growing technology / health promotion and training company that serves numerous Fortune 1,000 companies, internationally recognized health systems, and other major businesses. Hart holds a bachelor's degree in political science from University of Michigan and a law degree from Wayne State University Law School.

CFRA has a buy rating on the Pfizer (PFE) stock with a $45 price target. They also have a buy rating on Johnson & Johnson (JNJ) with a $177 price target, as well as Novavax (NVAX) with a $200 price target. Sel Hardy examines the outlook for these pharmaceutical stocks.

David Toung says the FDA panel is not expected to approve the resumption of JNJ's vaccine this week. For the company, the vaccine issue may not be a material concern to the company's earnings and revenue Medical devices are expected to show robust growth due to elective procedures and consumer health products are expected to show improving sales.

US equity markets edged higher after a choppy session, lifted by a defensive sectors and a rebound for technology stocks and as the latest political theatre unfolded in Washington - Dow dipped -8-points or -0.03%. Johnson & Johnson (JNJ) dipped -0.15% after the New York Times reported that the company unlikely to distribute as many COVID-19 vaccine doses in the spring as previously expected. Separately, the New England Journal of Medicine published trial data that showed Johnson & Johnson’s one-dose coronavirus vaccine is safe and appears to generate a promising immune response in both young and elderly volunteers. The broader S&P500 rose +0.23%, with Utilities (up +1.94%) and Real Estate (+1.39%) leading seven of the eleven primary sectors higher. Materials (down -1.06%), Industrials (-0.86%) and Energy (-0.81%) were the notable underperformers. Chipmaker Intel Corp gained +6.97% after it was announced that Chief Executive Officer (CEO) Bob Swan would step down effective 15 February, with VMWare Inc (down -6.79%) CEO Pat Gelsinger to step into the role. The Nasdaq gained +0.44%, with Apple Inc, Amazon.com Inc, Netflix Inc and Microsoft Corp advancing +1.62%, +1.44%, +2.74% and +0.66%, respectively. The small capitalisation Russell 2000 index fell -0.75% a day after hitting a fresh record closing high.

Top 5 Undervalued High Dividend Covid-19 Vaccine Stocks To Buy Now

This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher talking with Scott Martin, head of research at Kramer Capital Research. What might have been an episode focusing on the ramifications of last week's elections instead was dominated by Monday morning's vaccine update - Pfizer and BioNTech announcing positive preliminary data for their Covid-19 candidate. That news sent the Dow higher by more than 5% and the S&P 500 more than 3.5% at the time of recording. The Nasdaq - which housed many of the pandemic-favorite, work-from-home names - was in the red. Martin reminds that the Pfizer news might not be the golden bullet that ends the pandemic, and suggests the market may be over-reacting (indeed, by the close on Monday, the S&P had more than halved its early gain and the Nasdaq closed down 1.5%). He also notes that e-commerce isn't going away. A stock like Chewy (CHWY) - which fell nearly 12% on Monday - might be thought of as a pandemic stock, but it's really the future of pet supplies. Investors who missed the rip this year might be getting a buying opportunity. Treasurys are trash, says Martin. Why lock in an (inflation-adjusted) loss, says Martin, when names like Pfizer (PFE), General Mills (GIS), Johnson & Johnson (JNJ) - practically as safe as the government - yield plenty more? Getting to an election-related idea, the hosts and Martin discuss how to play the potential national de-criminalization of cannabis. Stay away from the growers, says Martin, as that's a commodity business. Instead, look for ways to invest in the consumer angle - gummies, edibles, soaps. Procter & Gamble (PG), Unilver (UL), General Mills may all get involved. As for pot names, Martin has been and continues to be a fan of Aphria (APHA) - medicinal, growing market share, into conventional pharma sales in Europe, and nearing profitability. Under any circumstances, Martin believes marijuana investments should be minor positions around one's major holdings. Listen to or subscribe to Alpha Trader on these podcast platforms: Apple Podcasts Spotify Google Play Stitcher Learn more about your ad choices. Visit megaphone.fm/adchoices

This week we are discussing the recent earnings announcements of Walgreens ($WBA) and Johnson & Johnson ($JNJ). We are both very excited that earnings season has really started now. There are many great Dividend Aristocrats and European Noble 30 members reporting earnings in the upcoming week. Actually, we declared next week 22 October as #DividendDay. Several great companies are reporting their earnings on that day: Unilever ($UL $UNA) Hermes International ($RMS), L'Oreal ($OR), AT&T ($T), Coca-Cola ($KO), Intel Corp. ($INTC), Kimberly-Clark ($KMB). Just join us Thursday 22 October at 10.30 CET or 9.30 GMT and let's share our thoughts on those earnings reports. Send EMF or European DGI a message on Twitter or via their blogs and we'll make sure that you'll get included. News from the week: EMF shares his reflection of the recent decision from IBM ($IBM) to spin off a part of the company. https://arstechnica.com/information-technology/2020/10/ibm-to-split-into-two-companies-by-the-end-of-2021/ eDGI shares the news that Mexico put a ban on a dozen of global dairy brands. They seem to not live up to the standards that the Mexican government has described. https://www.reuters.com/article/mexico-dairy/mexico-bans-global-brands-dairy-products-for-breaching-standards-idINL1N2H50WE Main Topic: EMF shares his reflection on the latest earning report of Walgreens. He is pretty happy with their earnings and feels that the company held up nicely during COVID-19. He also shares his thoughts about how he sees the company transforming very rapidly in a digital enterprise eDGI shares his reflection about Johnson and Johnson in which he is very impressed with again a “Clock-work” quarter of earnings. He shares a bit more about the highlights of their sales and earnings which investors should be aware of. After the main topic we addressed several listener questions: Phil - Hypothetically, if the current CEO of a company stepped down, and you had the choice between the CFO or CTO to step up as next CEO - who would you choose, and why? Danny - Any thoughts on space stocks such as Momentus thats meant to IPO start of 2021? Dividend Newbie - How long does it normally take to do a thorough analysis of a company before you feel ready to invest? Dividend Wave - 1 growth stock you have on the watchlist or have bought. and why? Check out Christophers analysis here https://seifelcapital.substack.com/p/sea-limited-nyse-se-summary-research RepStones - You buying BP at this level? Last but not least, we both shared our stock pick of the week. While you're at it, don't forget to hit the Subscribe and Like button

Trending Thursday is all about stocks making news! Does the news make them worthy to buy? or are you just getting caught up in the Hype? The VectorVest software can easily put things into perspective and help you make better decisions in what to do!Market Overview The stimulus is on, its off. Jobless claims are higher than lower. Interest rates will stay low for the foreseeable future. How do you make sense of all of the news to consistently make money in the market? I'll tell you how, Time the Market. We time the market by following the trend of the market and keeping our subscribers on the right side. Our Market Overview will make sure you are never blindsided by the market's actions! SPDR S&P 500 ETF Trust (SPY) & VectorVest Composite (VVC)Coronavirus StocksAnother company has halted testing this week for the vaccine. Operation Warp Speed was put into place to quickly find a vaccine for the pandemic we are in. How does this stoppage affect the company? Should you still buy it? Better yet, what companies are pushing forward and coming close to a vaccine? Most importantly, which companies can you buy that will make you some money? The question, how comfortable are you with the testing methods to get the vaccine to the American People? Johnson & Johnson (JNJ), AstraZeneca PLC (AZN), Eli Lilly and Company (LLY), Pfizer Inc. (PFE) & BioNTech SE (BNTX)5G StocksWith the release of the new iPhone and phones becoming 5G ready, is this industry ready to keep up with the hardware? Hmmm, let's take a look at the major phone carriers! Verizon Communications Inc. (VZ), T-Mobile US, Inc. (TMUS) & AT&T Inc. (T)Clean EnergyJuly 9th we started talking about this industry because the VV software pointed out that it was a hot industry! Folks that are 3 months ago you saw it here on YouTube Live! Since then, the EV space has bolstered this industry. We have had all kinds of stories about many of these up and coming companies. This week I wanted to do a deeper comparison of these stocks. You see some of these are news-driven trades, and some are bonafide longer term holds. The question, how many of you will consider buying an electric car in the near future? You don't want to miss this analysis! NIO Limited (NIO), Tesla, Inc. (TSLA), Workhorse Group Inc. (WKHS), Nikola Corporation (NKLA), SPI Energy Co., Ltd. (SPI)Stocks of interestEvery week I find stocks that make the news and catch my attention. I use the program to analyze the stocks to see if the news is warranted to buy the stock or stay away from it. This week I have added something extra. I will give you a stock that is “on my radar”, a stock to potentially keep your eyes on! The question, have you found any of these stocks of interest useful?  Apple Inc. (AAPL), Riot Blockchain, Inc. (RIOT), The Walt Disney Company (DIS) & The Goldfield Corporation (GV)

Johnson & Johnson (NYSE: JNJ) Q3 2020 earnings call dated Oct. 13, 2020 Johnson & Johnson (NYSE: JNJ) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported a 2% increase in Q3 revenues to $21.1 billion, beating the Wall Street consensus. Earnings of $2.20 per share were also stronger than what analysts had anticipated. JNJ shares were down 1.6% immediately following the announcement. The stock has gained 4% since the beginning of this year. Corporate Participants: Christopher DelOrefice — Vice President of Investor Relations Joseph J. Wolk — Executive Vice President and Chief Financial Officer Jennifer Taubert — Executive Vice President and Worldwide Chairman – Pharmaceuticals Ashley McEvoy — Executive Vice President, Worldwide Chairman, Medical Devices Thibaut Mongon — Executive Vice President, Worldwide Chairman, Consumer Health Mathai Mammen — Global Head of Janssen Research and Development Analysts: David Lewis — Morgan Stanley — Analyst Chris Schott — J.P. Morgan — Analyst Larry Biegelsen — Wells Fargo — Analyst Josh Jennings — Cowen & Company — Analyst Danielle-Antalffy — SVB Leerink — Analyst Terence Flynn — Goldman Sachs — Analyst Louise Chen — Cantor Fitzgerald — Analyst --- Send in a voice message: https://anchor.fm/earningspodcast/message Support this podcast: https://anchor.fm/earningspodcast/support

Markets roar higher due to options trading in the back ground, potential for more stimulus, good to see the green again. This is how the 11 stock market sectors are doing in 2020 compared against 2019 (% as of September 28, 2020): 11. Energy, -48.56% Companies in the energy sector explore, produce, refine, and market fuels such as oil, natural gas, and coal. Every company associated with the above, whether selling equipment to explore natural gas or refine oil, is also considered part of the energy sector. For example, companies include Exxon Mobil Corp. (XOM), Kinder Morgan (KMI), and Halliburton Co. (HAL) 10. Financials, -15.59% Companies in the financial sector deal with money, whether that be banking, capital markets, consumer finance, financial services, insurance, mortgages, or thrifts. When the finance sector collapses, others usually follow. This is one reason why the government bailed out several banks during the 2008 financial crisis (and why they’ve done so several times in the past). For example, companies include Bank of America Corp. (BAC), Visa (V), and PayPal Holdings (PYPL). 9. Real Estate, -11.42% Companies in the real estate sector include equity real estate investment trusts, and real estate management and development. One of the fastest-growing sectors in recent decades is real estate. With gains of around 97% since 2007. For example, companies include Redfin Corp. (RDFN), American Tower Corp. (AMT), and Simon Property Group (SPG). CHECK OUT: 5 low-risk investment opportunities right now. 8. Utilities, -8.97% Companies in the utility sector include electric utilities, gas utilities, renewable electricity producers, and water utilities. This highly regulated sector means the government keeps profit in check. Ensuring massive monopolies don’t charge ridiculous amounts for provinces that aren’t near water or power-plants. For example, companies include NextEra Energy (NEE), Duke Energy (DUK), and Exelon Corp. (EXC). 7. Industrials, -0.69% Companies in the industrial sector include aerospace, defense, air freight, airlines, building products, commercial services, construction, engineering, industrial conglomerates, machinery, marine industries, road, rail, and transportation infrastructure. The industrial sector includes many iconic blue-chip U.S. companies and an ideal place to do due diligence for long-term stock investments. For example, companies include Lockheed Martin Corp. (LMT), General Electric Co. (GE), and Caterpillar (CAT). 6. Consumer Staples, +4.07% Companies in the consumer staples sector include beverages, food retail, food products, household products, personal products, and tobacco. Due to the fact people always need products like toilet paper, soap, shampoo, etc., companies classed as offering consumer staples can make good long-term investments. That’s if they’re a popular and trusted brand or premises. So always do your due diligence. For example, companies include Coca-Cola Co. (KO), Procter & Gamble Co. (PG), and Walmart (WMT) 5. Materials, +8.63% Companies in the materials sector include chemicals, construction, containers, packaging, metals, mining, and forest products (paper). If the company turns raw materials into useful components, whether processed or natural, it is likely part of the materials’ stock market sector. For example, companies include Vale S.A. (VALE), Ecolab (ECL), and Rio Tinto (RIO). 4. Health Care, +14.45% Companies in the health care sector include biotechnology, equipment, supplies, providers, technology, life sciences, and pharmaceuticals. Health care falls into two categories, the application of services, technology, and medicine, or the creation of services, technology, and medicine. Like a few other sectors, health care is growing faster than the national economy. For example, companies include Abbott Laboratories (ABT), Johnson & Johnson (JNJ), and Pfizer (PFE). CHECK OUT: 10 stocks to watch if you’re on a budget of $10 or less. 3. Communication services, +14.73% Companies in the communication services sector include telecommunications, entertainment, interactive media, media, and wireless telecommunications. This sector is defined as media companies that also facilitate communication. It had to be defined as such as major companies that offered communication unified to provide internet, TV, mobile, and now even develop content for platforms. For example, companies include Comcast Corp. (CMCSA), Walt Disney Co. (DIS), and Verizon Communications (VZ). 2. Consumer Discretionary, +26.02% Companies in the consumer discretionary sector include communication equipment, electronic equipment, components, IT services, semiconductors, software, technology hardware, including storage and peripherals. Also known as the consumer cyclical sector, it encompasses everything that isn’t a day-to-day consumer necessity. For example, companies include Carnival Corp. (CCL), Grubhub (GRUB), and Lululemon Athletica (LULU). 1. Information Technology, +43.32% Companies in the information technology sector include automobile components and services, distributors, consumer services, hotels, restaurants, leisure, household durables, internet marketing, direct marketing, multiline and specialty retail, plus textiles, apparel, and luxury goods. Geographically dominated by Silicon Valley, the information technology sector is the #1 stock market sector so far this century. For example, companies include Apple (AAPL), Cisco Systems (CSCO), and Intel Corp. (INTC). See omnystudio.com/listener for privacy information.

Market overviewMarket direction is so important especially now that the market seems erratic. Do I hold on to my existing stocks? Do I start shorting now? I'm down in my positions, do I panic sell? Slow down! This is why we start off each session with market timing. Let me show you how to move fluidly with the current markets condition. SPDR S&P 500 ETF Trust (SPY) & VectorVest Composite (VVC) Coronavirus StocksOperation warp speed is in full force! A coronavirus vaccine is imminent. but wait! Are these vaccines going to be safe? We have seen and heard ads for people to go and support testing of these vaccines. Hmmmmm. Nonetheless there is money to be made on some of these stocks and let me walk you through the possibilities that abound! The Clorox Company (CLX), Johnson & Johnson (JNJ), MediciNova, Inc. (MNOV), Moderna, Inc. (MRNA), BioNTech SE (BNTX) & Pfizer Inc. (PFE) Clean Energy - EV'sClean energy has been on my radar for the last 3 months!!!! We have given you guys great opportunities to make money on these companies. Electric Vehicles have taken center stage in this industry. Everyone is trying to chase TSLA because they are the big boy in the group. Others see a great opportunity so let's see where the best trading opportunities are! BYD Company Limited (BYDDF), NIO Limited (NIO), XPeng Inc. (XPEV), Great Wall Motor Company Limited (GWLLF), SPI Energy Co., Ltd. (SPI) & Nikola Corporation (NKLA) Stocks of InterestStocks grab headlines and buzz. In this session we talk about some of the biggest news stories that come out on stocks that we know and don't know. These stocks may be ones to consider and some to stay away from. Just because they make the headlines does not always mean they are the best to buy. Let's take a gander at some buzz worthy stocks! Tesla, Inc. (TSLA), NIKE, Inc. (NKE), Amazon.com, Inc. (AMZN), Microsoft Corporation (MSFT) & Precipio, Inc. (PRPO)

This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher talking COVID-19 treatments and vaccinations with Adam Feuerstein of Stat News. Much of the treatment talk has been about Gilead's (GILD) remdesivir, and Feuerstein - who has been at the center of much of the reporting - takes us through those ups and downs. First, there was anecdotal evidence on April 16 out of Chicago which suggested the drug as being almost miraculously effective - the news set off a nice move higher in Gilead (more on that later), and a furious rally in the broader markets. Next, there was a "leak" one week later out of the WHO that a trial of the drug in China was a flop - the news took the starch out of a sizable rally in stocks that day. Finally, one day after that, there was a report that results from U.S. government's all-important trial of remdesivir were going to hit in mid-May, and chatter that those results might show the drug as being effective. Feuerstein does find it somewhat curious that Gilead's stock rises and falls with the news about remdesivir given that the company has more or less said it will give the drug away (after recouping costs). The halo effect? Possibly, but Gilead has added nearly $20B in market cap over the past three months. In any case, Gilead reports Q1 earnings after the close on Thursday - it might make for a good time to report on remdesivir results from one of the company trials (not from the above-mentioned U.S. government trial). Feuerstein reminds that remdesivir is only a treatment for COVID-19, and even in a best-case scenario will be effective in curing only certain patients. What the world ultimately needs is a vaccine, and there are currently five in clinical development, i.e. being tested on people. There are a number of others in pre-clinical development as well. One of the more advanced at this time is Moderna (MRNA), and that stock has nearly tripled over the past couple of months. Major pharmaceutical players (and experienced vaccine hands) Johnson & Johnson (JNJ), Pfizer (PFE), GlaxoSmithKline (GSK), and Sanofi (SNY) are also hard at work. Vaccines, however, take time to develop. If all goes right, says Feuerstein, we're looking at 12-18 months. Any stumbles, and it would take even longer.

Welcome to Dapper Dividends. I'm Russ and I'm a dividend growth investor that decided to start a podcast, cuz, why not! I will be making a few episodes a week to talk about anything on my mind related to dividends, the market in general or ANYTHING I want to, because it's my podcast!! Mentioned in this episode~ McDonalds (MCD), Johnson & Johnson (JNJ), Starbucks (SBUX), New Residential Investment Corp (NRZ), Simon Property Group (SPG) & Realty Income (O). Full Disclosure, I am long~ MCD, JNJ, SBUX, NRZ, SPG, O! Please rate, review and subscribe if you enjoy what I'm doing in pursuit of DAPPER DIVIDENDS! Disclaimer! All information contained here-within is not financial advice. I am not a licensed financial adviser and there is risk of significant loss investing in the stock market. This is my journey that I'm sharing for fun and entertainment.

In this podcast I reveal my 3rd largest dividend stock (by portfolio value), Johnson and Johnson (JNJ), in my passive income dividend portfolio (with plans to reveal another stock soon). Chat with me on my Dividend Discord Server ➜ https://discord.gg/kkSr5FY

In this episode, JC starts by talking about how the case for cutting interest rates may have strengthened and what that means for the market. He also talks about the earnings reports we have gotten so far this earnings season from Goldman Sachs (GS), JP Morgan (JPM), Bank of America (BAC), Johnson & Johnson (JNJ), and Netflix (NFLX). In addition, he talks about the pressure that Facebook is now facing from congress regarding "Libra" which is the new cryptocurrency they are planning to launch next year. www.ChamesEntertainment.com

Q&A starts at 34:11. If you don't want to wait until we publish it on this podcast, use our app to listen right away. Our app publishes these earnings calls shortly after they are available. We've created a dedicated earnings calls listening app with a library of thousands of calls. Our app lets you set "new call" notifications, download earnings calls, and see the date of the earnings call. App Store: https://itunes.apple.com/us/app/borsa-earnings-calls/id1414117603?mt=8 Google Play Store: https://play.google.com/store/apps/details?id=com.borsahq.earningscalls Weekly Email List (week's earnings calls, product updates, special offers, etc.): http://eepurl.com/dCZ5AH Video Demo: https://www.youtube.com/watch?v=OALinunnRjc&t=20s Welcome to Earnings Season. Our goal is to make listening to earnings calls easier. We upload relevant and newsworthy earnings calls for easy listening. To request a company's earnings call, email borsaHQ@gmail.com. App Store Play Store Twitter Instagram StockTwits

Courtney Billington is a senior executive at Johnson and Johnson (JnJ) where he’s the president of Janssen Neuroscience. He’s a long time veterans advocate and has a truly meaningful perspective on the importance of the military community in our country.  In this podcast, we cover a variety of topics, including: Army basketball and the importance of athletics J&J’s long history of supporting the military and veterans Why diversity and inclusion is so important How J&J is able to support veterans through their position as a global health care company, not only through hiring efforts. And much, much, more!

There’s an old market adage to buy when there’s “blood in the streets.” But there are plenty of ways to draw blood.In today’s litigious society, one such way is with a big lawsuit. From hot cups of coffee to weed killer that may be cancerous, it’s no surprise that America still leads the world in producing lawyers who need something to do—which usually means finding someone with deep pockets to sue.While many cases have their merits, a favorable jury will often hand out pretty sizeable sums—and that kind of news can set back the shares of a company’s price. The days of the biggest legal battle of them all, regarding the tobacco companies and healthcare costs, seem long past.But are they? In the twenty-first century, new legal battles are forming. And one place they’re forming in are in the opioid space. Abuse of opioids—legally and illegally—have been on the rise for a long time, and some places are starting to go after the companies that manufacture them.While some pharma companies have already settled with states to avoid the potential for large jury payouts, one company is bucking the trend. Johnson & Johnson (JNJ) is defending itself against the state of Oklahoma, which is suing the company on the basis that it helped to fuel the crisis. While we don’t know yet how this trial will end, we do know that these often high-visibility trails don’t kill companies—although they do hurt their share price in the short-run. From McDonald’s to the tobacco space, buying during times of literal trial are often the most profitable.Not sure the best way to get started? Follow these simple steps to hit the ground running... Step #1 - Get These FREE Reports:Big Book Of Chart Patterns: https://www.tradingtips.com/book-of-chart-patterns/The Ultimate Stock Trading Toolbox: https://www.tradingtips.com/ultimate-toolbox/ 10 Great Stocks Under $10: https://www.tradingtips.com/10-great-stocks-to-buy-under-10/7 Cheap & Good Stocks: https://reports.tradingtips.com/7-cheap-stocks Step #2 - Join Our Premium Advisories:The Next Superstock: https://www.tradingtips.com/3-disruptorsTriple Digit Returns: https://reports.tradingtips.com/pot-mania/Step #3 - Connect With The Community:Trading Tips Official Facebook Group: https://www.facebook.com/groups/tradingtipsdotcom/

In this episode, Jon addresses the question of whether or not Wall Street is evil, and whether or not it is worth it to continue putting any of your money into the stock market. He also talks about the earnings report we received this week from Dollar General (DG), in addition to the litigation facing Johnson & Johnson (JNJ). He also talks about how the trade war can continue to impact prices, especially now that Mexico is also getting hit with tariffs. www.ChamesEntertainment.com

In this episode we interview Bill Facteau who is Chairman, President and CEO of EarLens Corporation in Menlo Park California.  Bill joined Earlens Corporation as Chairman, President & CEO in November of 2013. Previously he acted as the Vice Chairman of ExploraMed Development, LLC, a medical device incubator based on the West Coast and as an Entrepreneur in Residence at New Enterprise Associates (NEA). Bill was at Johnson and Johnson (JNJ)as Worldwide President of their ENT Division. Facteau joined JNJ via the $800M acquisition of Acclarent, Inc. where he served as the President, CEO, and a member of the Board of Directors since the company’s formation in 2004.

Individuals who sit on five or more corporate boards - particularly at the largest U.S. corporations -- may not have the bandwidth to focus enough energy and time on each company's strategic and operational issues. At least that's the view of Kurt Schulzke, associate professor of Accounting & Law at the University of North Georgia and director of Kennesaw State University's Corporate Governance Center. Schultzke spoke with The Deal's Activist Investing Today podcast about overboarded directors, and his finding that some of the best-performing companies in the U.S., such as Starbucks Corp. (SBUX), Apple Inc. (AAPL) and Johnson & Johnson (JNJ), have directors who don't serve on many other boards.

This episode we discuss start with a review of the overall market and our stocks performance. Followed by Goodyear [GT -2.62%] paying laid off employees in tires instead of cash (33:35), Johnson & Johnson [JNJ -10.04%) allegedly concealed they knew about hazardous materials in their baby powder for almost 30 YEARS (38:11) with a discussion on the fear of loss versus the fear of investing (45:29) You Can find us on Facebook, iTunes and probably every other place where you get your Podcasts. Call and leave a message on our voicemail line 281.645.9205 and leave a rating on our Our iTunes page and if it five stars will read it on the air. Sales Force CRM [142.82]137.04 -4.05% Nike NKE [74.92]72.53 -3.19% Dollar Tree DLTR [86.77]85.86 -1.05% Pay Pal PYPL [85.81]85.92 0.13% Ollies Bargin Outlet OLLI [88.7]66.4 -25.14% Comcast CMCSA [38.89]36.34 -6.56% Orielly Auto ORLY [346.78] 348.17 0.40% Intel INTC [49.26] 47.86 0.40% FAWIC Index [913.95] 880.12 -3.70% S&P 500 [2760.16] 2599.95 -5.80% E Index [523.63]498.77 -4.75% C Index [390.32]381.35 -2.30% If you would like to support the show, you can sign up for A Robin hood account by following one of the two links in the show notes. Join Robinhood and you and one of the host will get a stock like Apple, Ford, or Sprint for free. https://share.robinhood.com/chrisw1140 https://share.robinhood.com/ellow

It's one of the largest healthcare companies in the world.  From medical devices, to drugs, to Band-Aids and Tylenol, Johnson and Johnson is the premier healthcare conglomerate in the United States. Johnson and Johnson's quality of earnings is so high, I am willing to bet that they are a company that will actually be around and earning a profit 50 years from now.  I found their credo inspiring, and their de-centralized business model helps them continue to grow at a steady pace in spite of their size.

Welcome to Episode #54 of the Zacks Market Edge Podcast. Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. In this episode, Tracey is joined by Jeremy Mullin, editor of Zacks Counterstrike portfolio service. For 10 years, Jeremy has been trading the after-hours trading sessions, both before the open and after the market closes. Tracey and Jeremy discuss the trading platforms you need to trade in the after-hours. It’s not as complicated as you may think. What are some of Jeremy’s top tips to trading stocks in the after-hours? 1. Stay away from “thick” stocks like Pfizer (PFE) that won’t have big moves. 2. Look for thinner stocks with bigger spreads, especially the hot stocks that will make big moves like Netflix (NFLX) and Baidu (BIDU) 3. Be nimble. Don’t be stubborn. 4. “You never go broke taking profits.” And there’s more. Jeremy and Tracey discuss the after-hours trade on some recent earnings reports including Johnson & Johnson (JNJ) and Domino’s Pizza (DPZ). What about trading the first earnings reports on recent IPOs? Jeremy shares his thoughts about jumping in on those in the after-hours. Want to know some of the lessons Jeremy has learned over the last decade? Tune into this week’s podcast to find out. Johnson and Johnson: https://www.zacks.com/stock/quote/JNJ?cid=cs-soundcloud-ft-pod Pfizer: https://www.zacks.com/stock/quote/PFE?cid=cs-soundcloud-ft-pod Netflix: https://www.zacks.com/stock/quote/NFLX?cid=cs-soundcloud-ft-pod Domino's Pizza; https://www.zacks.com/stock/quote/DPZ?cid=cs-soundcloud-ft-pod Baidu: https://www.zacks.com/stock/quote/BIDU?cid=cs-soundcloud-ft-pod

Welcome to Episode #40 of the Zacks Market Edge Podcast. Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. In this episode, Tracey is joined by Kevin Cook, Zacks Senior Stock Strategist and Editor of the Tactical Trader portfolio service. Kevin was on the podcast in January 2016 as stocks sold off, discussing what investors should do, and now he’s back just 6 months later with stocks at new all time highs. But the questions remain the same as in January: 1. What should investors do now? 2. Where are there values or opportunities? In June, Kevin discussed in a video how the S&P 500 could actually get to 2200 despite market valuations and sluggish growth. His conclusions then were that the Central Banks were making US equities the “stars” of investing. Basically, with bond yields so low, or negative, there is no other alternative. Additionally, the dividend yield on the S&P 500 is around 2%, which is much higher than the yield on the US 10-year. You can watch his video here. A lot of investors also have questions about valuations. Neither Tracey nor Kevin think that the S&P 500 is overvalued here. But, investors have to be picky. Many large cap stocks, even those with great fundamentals, have expensive valuations. Lockheed Martin (LMT), which just had a great second quarter earnings report, has a forward P/E of about 22. Johnson & Johnson (JNJ), which just guided higher for the year, has a forward P/E of 18. Neither is cheap. IBM (IBM) is one of the few large caps that seems to have value. It trades with a forward P/E of just 12. Where else should investors be looking for stock ideas? 1. The small caps haven’t yet reached new highs but do your homework. 2. Tracey and Kevin like the medical sector and there are opportunities outside of biotechs such as with the medical staffing companies like AMN Healthcare Services (AHS). 3. There are also some opportunities in technology with companies like Ambarella (AMBA). During market pullbacks, and during bull runs, Tracey and Kevin agree that there are always stock opportunities. What other tips do they have about buying at market tops? Tune into this week’s podcast to find out. IBM: https://www.zacks.com/stock/quote/IBM?cid=cs-soundcloud-ft-pod Johnson & Johnson; https://www.zacks.com/stock/quote/JNJ?cid=cs-soundcloud-ft-pod Lockheed Martin: https://www.zacks.com/stock/quote/LMT?cid=cs-soundcloud-ft-pod American Healthcare Solutions: https://www.zacks.com/stock/quote/AHS?cid=cs-soundcloud-ft-pod Ambarella: https://www.zacks.com/stock/quote/AMBA?cid=cs-soundcloud-ft-pod Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on Facebook: www.facebook.com/ZacksInvestmentResearch

In this episode, Tracey is joined by Kevin Matras, Zacks Vice President and portfolio manager of Zacks Options Trader service to talk about stock options: what they are and how you can trade them. Tracey admits she has never traded an option so Kevin starts off with the basics. What is an option? Options provide 3 advantages over regular stock trading: 1. Limited Risk 2. Leverage 3. Flexibility But there’s a bunch of things that beginners should learn before jumping in. What’s a call and a put? What’s the easiest of the two to use for beginning traders? Tracey always hears about being “in the money.” What does that mean? Kevin takes Tracey through three option examples that beginners would be able to execute, including Johnson & Johnson (JNJ), Simon Property Group (SPG) and Facebook (FB). With Facebook, he takes it one step further and discusses a bull call spread that can limit the profit potential but is a common strategy when options are expensive. While the options “lingo” may sound complex, “bull call what ???”, Kevin lays it out so even Tracey can understand it. If you’ve ever wondered how options work or thought about trying to trade them, then this is a must-listen podcast. Johnson & Johnson: http://www.zacks.com/stock/quote/JNJ?cid=cs-soundcloud-ft-pod Simon Property: http://www.zacks.com/stock/quote/SPG?cid=cs-soundcloud-ft-pod Facebook: http://www.zacks.com/stock/quote/FB?cid=cs-soundcloud-ft-pod Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on Facebook: www.facebook.com/ZacksInvestmentResearch

In this episode, Tracey is joined by Brian Bolan, Zacks Equity Strategist and Editor of the Game Changers and Stocks Under $10 portfolios. Berkshire Hathaway (BRKB) just held its annual shareholder meeting in Omaha which draws thousands of faithful Warren Buffett fans every year. As a result, for the entire weekend, the financial press was filled with quotes from Warren Buffett. Additionally, after the meeting, Warren Buffett, Charlie Munger and Bill Gates were interviewed for several hours on CNBC about their views on the economy and the stocks that Berkshire Hathaway owns, including IBM (IBM), Wells Fargo, American Express and Coca-Cola. Warren Buffett has given out a lot of advice over the years. But should you be following it? Brian has never been a Buffett fan, but being a value investor, Tracey has read books and articles about the Oracle of Omaha over the years. She was once a Berkshire Hathaway shareholder (of the B shares.) Have times changed since Buffett was investing in the 1970s which makes his advice less applicable to today’s market? And does the size of Berkshire Hathaway, which is a large cap, mean that Buffett can no longer invest in the small cap value names he was famous for? Brian does like one aspect of Buffett’s investing advice and that’s the buy and hold strategy but thinks the “hold” part is the most difficult for most investors. Tracey’s not a fan of the large cap dividend paying stocks that seem to dominate Berkshire’s stock portfolio now. Tracey and Brian discuss what stocks they like now (hint, they aren’t IBM.) Brian likes the disruptor technologies like the lending companies such as OnDeck Capital (ONDK) and Lending Club but also is a fan of the old line companies like Johnson & Johnson (JNJ) if you’re investing for the long haul and looking for a dividend. Tracey, following Buffett’s lead, likes companies with well known brands such as Snap-On (SNA) and Bank of the Ozarks (OZRK). Is the Oracle of Omaha still worth listening to in 2016? Check out this week’s podcast to find out. Snap-On Inc - http://www.zacks.com/stock/quote/SNA?cid=cs-soundcloud-ft-pod Bank of Ozarks: http://www.zacks.com/stock/quote/OZRK?cid=cs-soundcloud-ft-pod OnDeck Capital: http://www.zacks.com/stock/quote/ONDK?cid=cs-soundcloud-ft-pod Johnson & Johnson: http://www.zacks.com/stock/quote/JNJ?cid=cs-soundcloud-ft-pod Berkshire Hathaway: http://www.zacks.com/stock/quote/BRKB?cid=cs-soundcloud-ft-pod IBM: http://www.zacks.com/stock/quote/IBM?cid=cs-soundcloud-ft-pod Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on Facebook: www.facebook.com/ZacksInvestmentResearch

In this episode, Tracey is joined by Zacks’ Vice President, Editor of the Options Trader service and Zacks stock screening guru, Kevin Matras. The stock market is rocky to start the year, how can investors keep their emotions in check to find the best stocks to invest in? Kevin’s advice is to have a plan, whether it be stop-losses or something else, and stick to it. Kevin also divulges his favorite stock screens that use both fundamental and technical analysis to find the best Zacks #1 (Strong Buy) and #2 (Buy) stocks. They are screens he runs all the time. If you’re going to be invested in a volatile stock market, you might as well buy the stocks that have the best fundamentals. Kevin and Tracey also talk about the more basic stock screens that anyone can run that you can find on Zacks.com on the Screening tab. If you’re a Zacks Premium member, or if you take the 30-day free trial, you can access 20 more predefined screens that combine the Zacks Rank with Growth and Value criteria. These are some of the screens that Tracey runs regularly. Finally, Kevin and Tracey have stocks that they like even though this market seems ominous. They have different trading strategies. Kevin screens for stocks near their highs with solid fundamentals. Tracey likes stocks that have sold off. They both like the healthcare sector, with Lannett Inc. (LCI), Unitedhealth Group (UNH) and Johnson & Johnson (JNJ) being top picks. But a utility company, yes, a utility, and a defense contractor also make the grade. Still nervous about this stock market? Listen to this week’s podcast for Kevin and Tracey’s best ways to play this market pullback. Stock Screener: http://www.zacks.com/screening/stock-screener Research Wizard: https://woas.zacks.com/zcom/researchwizard/tools3.php?site=adid=Podcast Lannett Inc: http://www.zacks.com/stock/quote/LCI?cid=cs-soundcloud-ft-pod UnitedHealth Group: http://www.zacks.com/stock/quote/UNH?cid=cs-soundcloud-ft-pod Johnson & Johnson: http://www.zacks.com/stock/quote/JNJ?cid=cs-soundcloud-ft-pod Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on Facebook: www.facebook.com/ZacksInvestmentResearch